| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 42 | 2022 | 271 | 7.940 |
Why?
|
| Hospice and Palliative Care Nursing | 6 | 2022 | 17 | 2.560 |
Why?
|
| Pain Management | 14 | 2020 | 186 | 2.310 |
Why?
|
| Oncology Nursing | 8 | 2017 | 24 | 2.310 |
Why?
|
| Terminal Care | 13 | 2017 | 92 | 2.100 |
Why?
|
| Pain, Intractable | 8 | 2017 | 28 | 1.890 |
Why?
|
| Pain | 19 | 2020 | 472 | 1.810 |
Why?
|
| Neoplasms | 22 | 2021 | 1667 | 1.610 |
Why?
|
| Education, Nursing, Continuing | 6 | 2019 | 27 | 1.540 |
Why?
|
| Ketamine | 3 | 2020 | 57 | 1.540 |
Why?
|
| Analgesics, Opioid | 15 | 2020 | 498 | 1.340 |
Why?
|
| Analgesics | 6 | 2020 | 118 | 1.260 |
Why?
|
| Dyspnea | 6 | 2021 | 87 | 1.160 |
Why?
|
| Dexmedetomidine | 3 | 2019 | 13 | 1.140 |
Why?
|
| Analgesics, Non-Narcotic | 3 | 2019 | 45 | 1.090 |
Why?
|
| Societies, Nursing | 4 | 2019 | 24 | 1.040 |
Why?
|
| Fentanyl | 3 | 2020 | 26 | 1.000 |
Why?
|
| Curriculum | 8 | 2022 | 575 | 0.890 |
Why?
|
| Pain Measurement | 17 | 2019 | 328 | 0.860 |
Why?
|
| Infusion Pumps, Implantable | 5 | 2005 | 26 | 0.850 |
Why?
|
| Humans | 84 | 2022 | 68618 | 0.840 |
Why?
|
| Analgesia, Epidural | 4 | 2008 | 40 | 0.820 |
Why?
|
| Acute Pain | 2 | 2013 | 35 | 0.820 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2020 | 34 | 0.780 |
Why?
|
| Spirituality | 1 | 2021 | 38 | 0.750 |
Why?
|
| Hematemesis | 2 | 2019 | 14 | 0.720 |
Why?
|
| Vasopressins | 1 | 2019 | 33 | 0.690 |
Why?
|
| Burkitt Lymphoma | 1 | 2019 | 18 | 0.690 |
Why?
|
| Huntington Disease | 1 | 2019 | 15 | 0.680 |
Why?
|
| Hemoptysis | 1 | 2019 | 28 | 0.680 |
Why?
|
| Cancer Pain | 1 | 2019 | 3 | 0.680 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 107 | 0.660 |
Why?
|
| Short Bowel Syndrome | 1 | 2018 | 15 | 0.650 |
Why?
|
| Ileostomy | 1 | 2018 | 14 | 0.650 |
Why?
|
| Advanced Practice Nursing | 2 | 2018 | 36 | 0.630 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 51 | 0.630 |
Why?
|
| Referral and Consultation | 4 | 2018 | 383 | 0.620 |
Why?
|
| Terminally Ill | 2 | 2017 | 17 | 0.620 |
Why?
|
| Patient Care Team | 7 | 2015 | 311 | 0.600 |
Why?
|
| Nurse-Patient Relations | 1 | 2017 | 34 | 0.600 |
Why?
|
| Leadership | 1 | 2018 | 136 | 0.570 |
Why?
|
| Anemia, Sickle Cell | 5 | 2015 | 364 | 0.560 |
Why?
|
| Advance Directives | 4 | 2012 | 22 | 0.550 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2013 | 37 | 0.540 |
Why?
|
| Electric Stimulation Therapy | 2 | 2016 | 147 | 0.520 |
Why?
|
| Peptides | 1 | 2018 | 455 | 0.520 |
Why?
|
| Middle Aged | 31 | 2020 | 21147 | 0.520 |
Why?
|
| Injections, Spinal | 3 | 2005 | 18 | 0.520 |
Why?
|
| Models, Nursing | 2 | 2014 | 23 | 0.510 |
Why?
|
| Attitude of Health Personnel | 5 | 2011 | 442 | 0.500 |
Why?
|
| Home Care Services, Hospital-Based | 1 | 2014 | 6 | 0.490 |
Why?
|
| Nursing Staff, Hospital | 2 | 2014 | 62 | 0.490 |
Why?
|
| Professional-Family Relations | 2 | 2012 | 45 | 0.490 |
Why?
|
| Withholding Treatment | 1 | 2015 | 35 | 0.490 |
Why?
|
| Cancer Care Facilities | 1 | 2014 | 32 | 0.490 |
Why?
|
| Male | 33 | 2020 | 37321 | 0.480 |
Why?
|
| Female | 36 | 2020 | 38074 | 0.470 |
Why?
|
| Anesthetics, Local | 3 | 2010 | 83 | 0.470 |
Why?
|
| Adult | 24 | 2022 | 21403 | 0.450 |
Why?
|
| Clinical Competence | 6 | 2014 | 657 | 0.450 |
Why?
|
| Status Epilepticus | 1 | 2014 | 74 | 0.450 |
Why?
|
| Lidocaine | 2 | 2015 | 36 | 0.410 |
Why?
|
| Ambulatory Care | 1 | 2014 | 340 | 0.410 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 187 | 0.390 |
Why?
|
| Nurse's Role | 7 | 2018 | 66 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 5 | 2021 | 772 | 0.360 |
Why?
|
| Algorithms | 3 | 2011 | 1196 | 0.360 |
Why?
|
| Mouth Mucosa | 1 | 2010 | 51 | 0.350 |
Why?
|
| Fatal Outcome | 4 | 2019 | 164 | 0.350 |
Why?
|
| Quality of Life | 5 | 2018 | 1515 | 0.340 |
Why?
|
| Education, Nursing | 3 | 2018 | 55 | 0.340 |
Why?
|
| Drug Monitoring | 3 | 2008 | 107 | 0.340 |
Why?
|
| Professional-Patient Relations | 2 | 2019 | 71 | 0.330 |
Why?
|
| Morphine | 3 | 2005 | 76 | 0.330 |
Why?
|
| Chronic Pain | 3 | 2016 | 110 | 0.330 |
Why?
|
| Professional Competence | 1 | 2009 | 100 | 0.320 |
Why?
|
| Infusions, Parenteral | 2 | 2005 | 47 | 0.320 |
Why?
|
| Infusion Pumps | 2 | 2005 | 39 | 0.310 |
Why?
|
| Quality Improvement | 1 | 2011 | 413 | 0.300 |
Why?
|
| Cough | 2 | 2007 | 65 | 0.300 |
Why?
|
| Prostheses and Implants | 2 | 2005 | 159 | 0.290 |
Why?
|
| Aged | 15 | 2020 | 14862 | 0.280 |
Why?
|
| Nurses | 2 | 2018 | 53 | 0.270 |
Why?
|
| Drug Delivery Systems | 2 | 2005 | 236 | 0.270 |
Why?
|
| Program Evaluation | 5 | 2014 | 502 | 0.270 |
Why?
|
| Benchmarking | 2 | 2022 | 91 | 0.260 |
Why?
|
| Spine | 1 | 2005 | 46 | 0.250 |
Why?
|
| Cocaine | 1 | 2010 | 555 | 0.250 |
Why?
|
| United States | 10 | 2017 | 7367 | 0.240 |
Why?
|
| Hydromorphone | 1 | 2004 | 14 | 0.240 |
Why?
|
| Quality of Health Care | 5 | 2022 | 322 | 0.240 |
Why?
|
| Program Development | 4 | 2014 | 240 | 0.230 |
Why?
|
| Autonomic Nerve Block | 1 | 2003 | 15 | 0.220 |
Why?
|
| Diphenhydramine | 2 | 2014 | 13 | 0.220 |
Why?
|
| Antiemetics | 2 | 2014 | 8 | 0.220 |
Why?
|
| Lorazepam | 2 | 2014 | 54 | 0.220 |
Why?
|
| Drug Compounding | 1 | 2003 | 34 | 0.220 |
Why?
|
| Haloperidol | 2 | 2014 | 95 | 0.220 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 1536 | 0.220 |
Why?
|
| Clergy | 2 | 2021 | 7 | 0.210 |
Why?
|
| Sarcoma | 1 | 2003 | 70 | 0.210 |
Why?
|
| Nurse Practitioners | 1 | 2003 | 90 | 0.210 |
Why?
|
| Abdominal Pain | 1 | 2003 | 97 | 0.210 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 2 | 2015 | 40 | 0.210 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 100 | 0.210 |
Why?
|
| Pharmaceutical Preparations | 1 | 2003 | 101 | 0.200 |
Why?
|
| Decision Making | 2 | 2017 | 410 | 0.200 |
Why?
|
| Methadone | 3 | 2006 | 32 | 0.200 |
Why?
|
| Medical Oncology | 3 | 2022 | 110 | 0.200 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 135 | 0.200 |
Why?
|
| Communication | 5 | 2018 | 329 | 0.200 |
Why?
|
| Existentialism | 1 | 2021 | 3 | 0.200 |
Why?
|
| Academic Medical Centers | 5 | 2018 | 281 | 0.190 |
Why?
|
| Critical Care | 3 | 2015 | 263 | 0.180 |
Why?
|
| Treatment Outcome | 9 | 2015 | 7029 | 0.180 |
Why?
|
| Antineoplastic Agents | 3 | 2013 | 1070 | 0.180 |
Why?
|
| International Cooperation | 5 | 2014 | 88 | 0.180 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 36 | 0.180 |
Why?
|
| Drug Therapy, Combination | 3 | 2015 | 649 | 0.180 |
Why?
|
| Phobic Disorders | 1 | 2021 | 227 | 0.170 |
Why?
|
| Hospice Care | 2 | 2014 | 29 | 0.170 |
Why?
|
| Abdominal Neoplasms | 1 | 2019 | 22 | 0.170 |
Why?
|
| Education, Distance | 1 | 2019 | 34 | 0.170 |
Why?
|
| Death | 2 | 2011 | 38 | 0.170 |
Why?
|
| Pain Perception | 1 | 2019 | 22 | 0.170 |
Why?
|
| Life Support Care | 3 | 2015 | 12 | 0.170 |
Why?
|
| Statistics, Nonparametric | 1 | 2019 | 306 | 0.160 |
Why?
|
| Palliative Medicine | 1 | 2018 | 1 | 0.160 |
Why?
|
| Nursing Process | 1 | 2018 | 7 | 0.160 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 96 | 0.160 |
Why?
|
| Parenteral Nutrition | 1 | 2018 | 39 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2014 | 714 | 0.160 |
Why?
|
| Administrative Personnel | 1 | 2018 | 22 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2019 | 1851 | 0.160 |
Why?
|
| Inservice Training | 2 | 2009 | 68 | 0.160 |
Why?
|
| Professional Practice | 1 | 2018 | 47 | 0.160 |
Why?
|
| Caregivers | 1 | 2022 | 365 | 0.160 |
Why?
|
| Nursing Research | 1 | 2018 | 40 | 0.150 |
Why?
|
| Nursing Assessment | 4 | 2006 | 70 | 0.150 |
Why?
|
| Health Services Accessibility | 2 | 2014 | 581 | 0.150 |
Why?
|
| Dermatomyositis | 1 | 2017 | 31 | 0.150 |
Why?
|
| Health Care Surveys | 3 | 2014 | 239 | 0.150 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 168 | 0.150 |
Why?
|
| Morpholines | 1 | 2017 | 79 | 0.150 |
Why?
|
| Neuralgia | 1 | 2017 | 27 | 0.150 |
Why?
|
| Tissue and Organ Procurement | 2 | 2011 | 164 | 0.150 |
Why?
|
| Educational Measurement | 2 | 2009 | 254 | 0.140 |
Why?
|
| Health Policy | 1 | 2018 | 221 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2800 | 0.140 |
Why?
|
| Nausea | 2 | 2014 | 47 | 0.130 |
Why?
|
| Time Management | 1 | 2015 | 12 | 0.130 |
Why?
|
| Drug Administration Schedule | 2 | 2008 | 567 | 0.130 |
Why?
|
| Young Adult | 4 | 2015 | 5717 | 0.130 |
Why?
|
| Hypoxia, Brain | 1 | 2014 | 16 | 0.120 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2014 | 11 | 0.120 |
Why?
|
| Low Back Pain | 1 | 2015 | 45 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 1 | 2014 | 27 | 0.120 |
Why?
|
| Critical Care Nursing | 1 | 2014 | 4 | 0.120 |
Why?
|
| Euthanasia, Passive | 2 | 2011 | 3 | 0.120 |
Why?
|
| Propofol | 1 | 2014 | 36 | 0.120 |
Why?
|
| Administration, Topical | 2 | 2014 | 111 | 0.120 |
Why?
|
| Administration, Oral | 2 | 2013 | 411 | 0.120 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 76 | 0.120 |
Why?
|
| Focus Groups | 1 | 2014 | 247 | 0.110 |
Why?
|
| Thalassemia | 1 | 2013 | 7 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 123 | 0.110 |
Why?
|
| Retrospective Studies | 5 | 2020 | 7277 | 0.110 |
Why?
|
| Inpatients | 1 | 2014 | 208 | 0.110 |
Why?
|
| Patient Care Planning | 4 | 2010 | 108 | 0.110 |
Why?
|
| Resuscitation Orders | 1 | 2012 | 12 | 0.110 |
Why?
|
| Taste Disorders | 1 | 2012 | 3 | 0.100 |
Why?
|
| Zinc Sulfate | 1 | 2012 | 4 | 0.100 |
Why?
|
| Child | 2 | 2022 | 6405 | 0.100 |
Why?
|
| Gene Expression | 1 | 2015 | 770 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1745 | 0.100 |
Why?
|
| Epoprostenol | 1 | 2012 | 71 | 0.100 |
Why?
|
| Resuscitation | 1 | 2012 | 77 | 0.100 |
Why?
|
| Nursing Education Research | 1 | 2011 | 35 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2012 | 100 | 0.100 |
Why?
|
| Organizational Policy | 1 | 2011 | 42 | 0.100 |
Why?
|
| Hospitals, Teaching | 1 | 2011 | 65 | 0.100 |
Why?
|
| Physicians | 1 | 2015 | 324 | 0.100 |
Why?
|
| Social Support | 2 | 2005 | 423 | 0.100 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 93 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2012 | 113 | 0.100 |
Why?
|
| Activities of Daily Living | 1 | 2013 | 319 | 0.100 |
Why?
|
| Time Factors | 4 | 2013 | 4655 | 0.100 |
Why?
|
| Aminocaproates | 1 | 2010 | 4 | 0.090 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2011 | 99 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 4848 | 0.090 |
Why?
|
| Olfaction Disorders | 1 | 2012 | 100 | 0.090 |
Why?
|
| Communication Barriers | 2 | 2011 | 48 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2011 | 186 | 0.090 |
Why?
|
| Tongue Neoplasms | 1 | 2010 | 29 | 0.090 |
Why?
|
| Attitude to Death | 1 | 2010 | 52 | 0.090 |
Why?
|
| Medical Records | 1 | 2010 | 121 | 0.090 |
Why?
|
| Treatment Failure | 2 | 2007 | 216 | 0.090 |
Why?
|
| Patient Safety | 1 | 2011 | 202 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2012 | 232 | 0.080 |
Why?
|
| Specialties, Nursing | 2 | 2011 | 7 | 0.080 |
Why?
|
| Skin | 1 | 2012 | 451 | 0.080 |
Why?
|
| Poverty | 1 | 2010 | 219 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 371 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 170 | 0.080 |
Why?
|
| Double-Blind Method | 4 | 2015 | 1738 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2014 | 304 | 0.080 |
Why?
|
| Narcotics | 2 | 2005 | 65 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 185 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2010 | 384 | 0.080 |
Why?
|
| Injections, Epidural | 1 | 2008 | 6 | 0.080 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 1506 | 0.080 |
Why?
|
| Antitussive Agents | 1 | 2007 | 3 | 0.070 |
Why?
|
| Nursing Evaluation Research | 1 | 2007 | 46 | 0.070 |
Why?
|
| Cross-Sectional Studies | 2 | 2011 | 2279 | 0.070 |
Why?
|
| Aerosols | 1 | 2007 | 42 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2010 | 301 | 0.070 |
Why?
|
| Patient Advocacy | 2 | 2006 | 40 | 0.070 |
Why?
|
| Nonverbal Communication | 1 | 2006 | 4 | 0.070 |
Why?
|
| Communication Disorders | 1 | 2006 | 12 | 0.070 |
Why?
|
| Opioid-Related Disorders | 1 | 2010 | 298 | 0.070 |
Why?
|
| Virginia | 3 | 2014 | 45 | 0.070 |
Why?
|
| Clinical Protocols | 1 | 2007 | 172 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2009 | 335 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2007 | 136 | 0.070 |
Why?
|
| Patient Education as Topic | 2 | 2006 | 425 | 0.070 |
Why?
|
| Decision Trees | 1 | 2005 | 74 | 0.060 |
Why?
|
| Torsades de Pointes | 1 | 2005 | 5 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2006 | 142 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2010 | 629 | 0.060 |
Why?
|
| Clonidine | 1 | 2004 | 66 | 0.060 |
Why?
|
| Self Report | 2 | 2019 | 371 | 0.060 |
Why?
|
| Celiac Plexus | 1 | 2003 | 2 | 0.060 |
Why?
|
| Weather | 1 | 2003 | 9 | 0.060 |
Why?
|
| Drug Overdose | 1 | 2004 | 67 | 0.060 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2004 | 50 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2014 | 1342 | 0.060 |
Why?
|
| Bupivacaine | 1 | 2003 | 27 | 0.060 |
Why?
|
| World Health Organization | 1 | 2003 | 53 | 0.060 |
Why?
|
| Biological Availability | 1 | 2003 | 79 | 0.050 |
Why?
|
| Spouses | 1 | 2003 | 51 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2003 | 117 | 0.050 |
Why?
|
| Drug Costs | 1 | 2003 | 87 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2003 | 110 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2003 | 131 | 0.050 |
Why?
|
| Teaching | 1 | 2004 | 169 | 0.050 |
Why?
|
| Self Efficacy | 1 | 2003 | 199 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2005 | 1330 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2003 | 206 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 1054 | 0.050 |
Why?
|
| Temperature | 1 | 2003 | 341 | 0.050 |
Why?
|
| Cost Savings | 1 | 2002 | 110 | 0.050 |
Why?
|
| Internship and Residency | 1 | 2007 | 596 | 0.050 |
Why?
|
| Self Care | 1 | 2003 | 253 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2003 | 299 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2003 | 446 | 0.050 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 332 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2003 | 447 | 0.040 |
Why?
|
| Consciousness Disorders | 1 | 2019 | 7 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2005 | 2358 | 0.040 |
Why?
|
| Ethics, Nursing | 1 | 2018 | 10 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2018 | 64 | 0.040 |
Why?
|
| Job Satisfaction | 1 | 2018 | 62 | 0.040 |
Why?
|
| Critical Illness | 1 | 2019 | 191 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2005 | 3705 | 0.040 |
Why?
|
| Hospitalization | 1 | 2003 | 978 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2003 | 711 | 0.040 |
Why?
|
| Dementia | 2 | 2011 | 158 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2018 | 369 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2015 | 55 | 0.030 |
Why?
|
| Data Collection | 1 | 2016 | 420 | 0.030 |
Why?
|
| Intensive Care Units | 2 | 2010 | 344 | 0.030 |
Why?
|
| Gels | 1 | 2014 | 55 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 334 | 0.030 |
Why?
|
| Ambulatory Care Facilities | 1 | 2014 | 91 | 0.030 |
Why?
|
| Vomiting | 1 | 2014 | 56 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 260 | 0.030 |
Why?
|
| Perception | 1 | 2014 | 189 | 0.030 |
Why?
|
| Infant | 2 | 2011 | 2891 | 0.030 |
Why?
|
| Absorption | 1 | 2012 | 49 | 0.030 |
Why?
|
| Administration, Cutaneous | 1 | 2012 | 56 | 0.030 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2012 | 25 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 8912 | 0.020 |
Why?
|
| Kenya | 1 | 2011 | 26 | 0.020 |
Why?
|
| Taxoids | 1 | 2010 | 41 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2010 | 40 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2011 | 129 | 0.020 |
Why?
|
| Bortezomib | 1 | 2010 | 45 | 0.020 |
Why?
|
| Pyrazines | 1 | 2010 | 46 | 0.020 |
Why?
|
| Stomach Ulcer | 1 | 2010 | 14 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2016 | 703 | 0.020 |
Why?
|
| Oncology Service, Hospital | 1 | 2010 | 9 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 1 | 2010 | 33 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 93 | 0.020 |
Why?
|
| Hospices | 1 | 2010 | 14 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 46 | 0.020 |
Why?
|
| Tanzania | 1 | 2010 | 35 | 0.020 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2010 | 48 | 0.020 |
Why?
|
| Geography | 1 | 2010 | 80 | 0.020 |
Why?
|
| Health Promotion | 1 | 2014 | 407 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2010 | 61 | 0.020 |
Why?
|
| Health Literacy | 1 | 2010 | 63 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2011 | 177 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2009 | 117 | 0.020 |
Why?
|
| Minority Groups | 1 | 2010 | 197 | 0.020 |
Why?
|
| Health Personnel | 1 | 2011 | 286 | 0.020 |
Why?
|
| Software | 1 | 2010 | 418 | 0.020 |
Why?
|
| Risk Factors | 2 | 2010 | 5731 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2008 | 149 | 0.020 |
Why?
|
| Principle-Based Ethics | 1 | 2006 | 3 | 0.020 |
Why?
|
| Unconsciousness | 1 | 2006 | 6 | 0.020 |
Why?
|
| Codes of Ethics | 1 | 2006 | 11 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 334 | 0.020 |
Why?
|
| Professional Role | 1 | 2007 | 80 | 0.020 |
Why?
|
| Therapeutic Equivalency | 1 | 2006 | 21 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 2006 | 99 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2008 | 652 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2011 | 3187 | 0.020 |
Why?
|
| Patient Participation | 1 | 2006 | 146 | 0.010 |
Why?
|
| Salvage Therapy | 1 | 2005 | 82 | 0.010 |
Why?
|
| Teaching Materials | 1 | 2004 | 16 | 0.010 |
Why?
|
| Interprofessional Relations | 1 | 2006 | 188 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2007 | 267 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 63 | 0.010 |
Why?
|
| Models, Educational | 1 | 2004 | 67 | 0.010 |
Why?
|
| Constipation | 1 | 2004 | 32 | 0.010 |
Why?
|
| Meteorological Concepts | 1 | 2003 | 4 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2010 | 2007 | 0.010 |
Why?
|
| Length of Stay | 1 | 2007 | 780 | 0.010 |
Why?
|
| Medicine | 1 | 2003 | 52 | 0.010 |
Why?
|
| Specialization | 1 | 2003 | 66 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2005 | 261 | 0.010 |
Why?
|
| Fatigue | 1 | 2004 | 132 | 0.010 |
Why?
|
| Seasons | 1 | 2003 | 129 | 0.010 |
Why?
|
| Health Services Research | 1 | 2003 | 209 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 658 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1864 | 0.010 |
Why?
|
| Anxiety | 1 | 2004 | 422 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 2455 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 1553 | 0.010 |
Why?
|
| Depression | 1 | 2004 | 943 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 20881 | 0.010 |
Why?
|